Inogen, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Earnings per Share (Tables)

Earnings per Share (Tables)

3 Months Ended

Mar. 31, 2018

The computation of EPS is as follows:

	Three months ended March 31,
	2018		2017
Numerator—basic and diluted:
Net income	$	10,758	$	5,932

Denominator:
Weighted-average common shares - basic common stock ⁽¹⁾		21,026,154		20,489,532
Weighted-average common shares - diluted common stock		22,295,213		21,579,721

Net income per share - basic common stock	$	0.51	$	0.29
Net income per share - diluted common stock	$	0.48	$	0.27

Denominator calculation from basic to diluted:
Weighted-average common shares - basic common stock ⁽¹⁾		21,026,154		20,489,532
Stock options and other dilutive awards		1,269,059		1,090,189
Weighted-average common shares - diluted common stock		22,295,213		21,579,721
Shares excluded from diluted weighted-average shares:
Stock options		—		25,700
Restricted stock units and restricted stock awards		75,926		—
Shares excluded from diluted weighted-average shares		75,926		25,700

(1) Unvested restricted stock units and restricted stock awards are not included as shares outstanding in the calculation of basic earnings per share. Vested restricted stock units and restricted stock awards are included in basic earnings per share if all vesting and performance criteria have been met. Performance-based restricted stock units and restricted stock awards are included in the number of shares used to calculate diluted earnings per share as long as all applicable performance criteria are met, and their effect is dilutive. Restricted stock awards are eligible to receive all dividends declared on the Company’s common shares during the vesting period; however, such dividends are not paid until the restrictions lapse.